Effect of the ALL App on Literacy for Children Who Use AAC
Launched by PENN STATE UNIVERSITY · Oct 26, 2022
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Students with CCN can participate if they meet the following criteria:
- • 3 to 10 years old
- • present with speech and communication skills that did not meet all of their daily communication needs (e.g., have an AAC system; less than 50% intelligible at the single word level to unfamiliar partners if using speech)
- • follow one-step directions
- • symbolic communicators with use of at least 50 words/signs/picture icons expressively,
- • limited literacy skills (i.e., identify less than 26 letter-sound correspondences, 10 words during sound blending, 25 sight words on the screening assessment, and can spell less that 20 words)
- • not receiving consistent phonologically-based direct literacy instruction or receiving instruction in less than 2 of the tested skills
- • unimpaired or corrected vision and hearing
- • access to an iPad
- School support personnel (e.g., teachers, speech-pathologists, paraprofessionals) can participate if they meet the following criteria, per self-report:
- • Speaks English
- • Reads English
- • 18 years of age or older
- • Spending time directly working with an individual with CCN who needs to learn to read
- • Willingness to implement the ALL curriculum and incorporate it into the daily educational plans
- Exclusion Criteria:
- Students cannot participate if they:
- • are under 3 years of age
- • do not present with severe speech disorders whereby they could use or benefit from AAC
- • can't follow one-step directions
- • are not symbolic communicators
- • are able to read at the connected text level
- • do not speak/understand English
- • impaired and uncorrected vision and hearing
- • do not have access to an iPad to use the ALL app
- Support personnel cannot participate if they:
- • do not speak English
- • do not understand English
- • have impaired vision and hearing that is not corrected and impacts reading and hearing the child they work with
- • are not in daily direct contact with someone with CCN
- • unwilling to attend trainings related to the ALL app
- • unwilling to incorporate the ALL app into daily educational plans
About Penn State University
Penn State University is a leading research institution renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical trials. As a prominent sponsor of clinical research, the university leverages its diverse expertise across various medical fields to conduct rigorous studies aimed at evaluating new treatments, interventions, and healthcare strategies. With a strong emphasis on collaboration, ethical standards, and patient safety, Penn State University is dedicated to translating research findings into real-world applications that enhance the well-being of communities and contribute to the broader scientific landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
State College, Pennsylvania, United States
Patients applied
Trial Officials
Jessica Caron, Ph.D.
Principal Investigator
The Pennsylvania State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials